NO20003273L - Substituerte <beta>-alaniner - Google Patents
Substituerte <beta>-alaninerInfo
- Publication number
- NO20003273L NO20003273L NO20003273A NO20003273A NO20003273L NO 20003273 L NO20003273 L NO 20003273L NO 20003273 A NO20003273 A NO 20003273A NO 20003273 A NO20003273 A NO 20003273A NO 20003273 L NO20003273 L NO 20003273L
- Authority
- NO
- Norway
- Prior art keywords
- beta
- compounds
- prodrugs
- halogen
- hydrogen
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 229940002612 prodrug Drugs 0.000 abstract 2
- 239000000651 prodrug Substances 0.000 abstract 2
- 102000016359 Fibronectins Human genes 0.000 abstract 1
- 108010067306 Fibronectins Proteins 0.000 abstract 1
- 108010008212 Integrin alpha4beta1 Proteins 0.000 abstract 1
- 108010000134 Vascular Cell Adhesion Molecule-1 Proteins 0.000 abstract 1
- 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Indole Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Polyamides (AREA)
- Peptides Or Proteins (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9727532.5A GB9727532D0 (en) | 1997-12-23 | 1997-12-23 | Chemical compounds |
| US9260298P | 1998-07-13 | 1998-07-13 | |
| PCT/GB1998/003859 WO1999033789A1 (en) | 1997-12-23 | 1998-12-23 | SUBSTITUTED β-ALANINES |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20003273D0 NO20003273D0 (no) | 2000-06-22 |
| NO20003273L true NO20003273L (no) | 2000-06-22 |
Family
ID=26312873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20003273A NO20003273L (no) | 1997-12-23 | 2000-06-22 | Substituerte <beta>-alaniner |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1042279B1 (de) |
| JP (1) | JP4555469B2 (de) |
| KR (1) | KR20010033520A (de) |
| CN (1) | CN1163477C (de) |
| AT (1) | ATE289991T1 (de) |
| AU (1) | AU747907B2 (de) |
| BR (1) | BR9814376A (de) |
| CA (1) | CA2316235A1 (de) |
| CZ (1) | CZ20002342A3 (de) |
| DE (1) | DE69829215T2 (de) |
| ES (1) | ES2235383T3 (de) |
| HU (1) | HUP0101701A3 (de) |
| IL (1) | IL136584A (de) |
| NO (1) | NO20003273L (de) |
| NZ (1) | NZ505363A (de) |
| SK (1) | SK9372000A3 (de) |
| TR (1) | TR200001947T2 (de) |
| WO (1) | WO1999033789A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1294576A (zh) * | 1998-01-23 | 2001-05-09 | 诺瓦提斯公司 | Vla－4拮抗剂 |
| WO2000039103A1 (en) * | 1998-12-23 | 2000-07-06 | Aventis Pharma Limited | Dihydro-benzo(1,4)oxazines and tetrahydroquinoxalines |
| CA2362831C (en) * | 1999-02-18 | 2008-10-07 | F. Hoffmann-La Roche Ag | Thioamide derivatives |
| YU41202A (sh) * | 1999-12-28 | 2005-03-15 | Pfizer Products Inc. | Ne-peptidni inhibitori vezivanja za ćeliju zavisnog od vla-4 korisni pri tretiranju inflamatornih, autoimunih i respiratornih bolesti |
| DE10019755A1 (de) * | 2000-04-20 | 2001-11-08 | Bayer Ag | Neue Aminoaryl/cycloalkylcarbonsäuren als Integrinantagonisten |
| FR2812633A1 (fr) * | 2000-08-04 | 2002-02-08 | Aventis Cropscience Sa | Derives de phenyl(thio)urees et phenyl(thio)carbamates fongicides |
| GB2367816A (en) | 2000-10-09 | 2002-04-17 | Bayer Ag | Urea- and thiourea-containing derivatives of beta-amino acids |
| GB2369357A (en) * | 2000-10-09 | 2002-05-29 | Bayer Ag | Aliphatic, cyclic amino carboxylic acids as integrin antagonists |
| CA2427750C (en) | 2000-11-04 | 2011-01-04 | Aventis Pharma Limited | Substituted alkanoic acids |
| CA2430978C (en) | 2000-12-28 | 2012-05-15 | Daiichi Pharmaceutical Co., Ltd. | Vla-4 inhibitors |
| GB2377933A (en) | 2001-07-06 | 2003-01-29 | Bayer Ag | Succinic acid derivatives useful as integrin antagonists |
| JP4676884B2 (ja) | 2003-07-24 | 2011-04-27 | 第一三共株式会社 | シクロヘキサンカルボン酸類 |
| EP1874283A4 (de) * | 2005-04-28 | 2011-11-02 | Ferring Bv | Verwendung neuer verbindungen zur behandlung von ibd |
| EP1961750B1 (de) | 2005-12-13 | 2013-09-18 | Daiichi Sankyo Company, Limited | Vla-4-hemmendes arzneimittel |
| AU2008219007A1 (en) | 2007-02-20 | 2008-08-28 | Merrimack Pharmaceuticals, Inc. | Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6306840B1 (en) * | 1995-01-23 | 2001-10-23 | Biogen, Inc. | Cell adhesion inhibitors |
| MX9801716A (es) * | 1995-08-30 | 1998-05-31 | Searle & Co | Derivados de meta-guanidina, urea, tiourea o acido aminobenzoico azaciclico, como antagonistas de integrina. |
| DE69706407T2 (de) * | 1996-03-29 | 2002-05-29 | G.D. Searle & Co., Chicago | META-SUBSTITUIERTE PHENYLENDERIVATE UND IHRE VERWENDUNG ALS ALPHAvBETA3 INTERGRIN-ANTAGONISTEN ODER INHIBITOREN |
| DK0891325T3 (da) * | 1996-03-29 | 2002-05-21 | Searle & Co | Para-substituerede phenylpropansyrederivater som integrinantagonister |
| DK1027328T3 (da) * | 1997-10-31 | 2006-11-13 | Aventis Pharma Ltd | Substituerede anilider |
-
1998
- 1998-12-23 SK SK937-2000A patent/SK9372000A3/sk unknown
- 1998-12-23 NZ NZ505363A patent/NZ505363A/en unknown
- 1998-12-23 AU AU17719/99A patent/AU747907B2/en not_active Ceased
- 1998-12-23 CZ CZ20002342A patent/CZ20002342A3/cs unknown
- 1998-12-23 EP EP98962586A patent/EP1042279B1/de not_active Expired - Lifetime
- 1998-12-23 CA CA002316235A patent/CA2316235A1/en not_active Abandoned
- 1998-12-23 DE DE69829215T patent/DE69829215T2/de not_active Expired - Lifetime
- 1998-12-23 ES ES98962586T patent/ES2235383T3/es not_active Expired - Lifetime
- 1998-12-23 BR BR9814376-0A patent/BR9814376A/pt not_active Application Discontinuation
- 1998-12-23 HU HU0101701A patent/HUP0101701A3/hu unknown
- 1998-12-23 CN CNB988125005A patent/CN1163477C/zh not_active Expired - Fee Related
- 1998-12-23 JP JP2000526473A patent/JP4555469B2/ja not_active Expired - Lifetime
- 1998-12-23 AT AT98962586T patent/ATE289991T1/de not_active IP Right Cessation
- 1998-12-23 WO PCT/GB1998/003859 patent/WO1999033789A1/en not_active Ceased
- 1998-12-23 KR KR1020007007022A patent/KR20010033520A/ko not_active Ceased
- 1998-12-23 IL IL13658498A patent/IL136584A/xx not_active IP Right Cessation
- 1998-12-23 TR TR2000/01947T patent/TR200001947T2/xx unknown
-
2000
- 2000-06-22 NO NO20003273A patent/NO20003273L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ20002342A3 (cs) | 2001-11-14 |
| HUP0101701A2 (hu) | 2001-11-28 |
| CN1283181A (zh) | 2001-02-07 |
| IL136584A0 (en) | 2001-06-14 |
| JP2001527061A (ja) | 2001-12-25 |
| DE69829215T2 (de) | 2005-07-21 |
| NO20003273D0 (no) | 2000-06-22 |
| HK1034508A1 (en) | 2001-10-26 |
| NZ505363A (en) | 2005-02-25 |
| IL136584A (en) | 2005-03-20 |
| ES2235383T3 (es) | 2005-07-01 |
| TR200001947T2 (tr) | 2001-01-22 |
| EP1042279B1 (de) | 2005-03-02 |
| AU747907B2 (en) | 2002-05-30 |
| CA2316235A1 (en) | 1999-07-08 |
| BR9814376A (pt) | 2000-10-10 |
| DE69829215D1 (de) | 2005-04-07 |
| HUP0101701A3 (en) | 2003-02-28 |
| KR20010033520A (ko) | 2001-04-25 |
| CN1163477C (zh) | 2004-08-25 |
| EP1042279A1 (de) | 2000-10-11 |
| AU1771999A (en) | 1999-07-19 |
| ATE289991T1 (de) | 2005-03-15 |
| JP4555469B2 (ja) | 2010-09-29 |
| WO1999033789A1 (en) | 1999-07-08 |
| SK9372000A3 (en) | 2002-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE289991T1 (de) | Substituierte beta-alaninen | |
| DK1027328T3 (da) | Substituerede anilider | |
| ATE206611T1 (de) | Verwendung von mangiferin oder seinen derivaten zur kosmetischen anwendung | |
| TR200102959T2 (tr) | İntegrin antagonistleri olarak ikame edilmiş bisiklik heteroaril bileşikleri | |
| HUP0204496A2 (en) | Novel piperidine compounds and pharmaceutical compositions containing the same and process for preparation the same | |
| IT1295694B1 (it) | Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica | |
| ES2124545T3 (es) | Azolidindionas como agentes antihiperglucemicos. | |
| GB9408185D0 (en) | New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same | |
| FR2712591B1 (fr) | Nouvelles arylpipérazines dérivées d'indole, leur préparation et leur utilisation thérapeutique. | |
| CO4820432A1 (es) | Composiciones farmaceuticas para el tratamiento de rinitis que comprenden acido 2-(4-(difenilmetil)-1-piperacinil)-ace- tico o amida derivada y un compuesto seleccionado de pseudoe fedrina,fenilpropanolamina y fenilefrina | |
| ATE165368T1 (de) | Inhibitoren von testosteron-5-alpha reductase. | |
| ATE126221T1 (de) | Thiazolidinverbindeungen, deren herstellung und therapeutische verwendung. | |
| CO4410329A1 (es) | Nuevos pirrolocarbazoles | |
| NO944892L (no) | N-substituerte 3-azabicyklo (3.2.0) hepatanderivater som neuroleptika osv. | |
| DE69402935D1 (de) | Substituierte arylalkylaminobenzyl-aminopropanamide, ihre herstellung und verwendung als antiepileptische, neuroprotektive und antidepressive mittel | |
| PT1068184E (pt) | Derivados n-ariloxietilamina para o tratamento de depressao | |
| EP0638564A4 (de) | Benzothiazolsulfonamid-derivate, verfahren zu deren herstellung und anwendungen. | |
| NO950177L (no) | Farmakologisk aktive erivater | |
| ATE245986T1 (de) | Verwendung von 8-nitro-2,3,4,5-tetrahydro-1h-3- benzazepinen zur herstellung von pharmazeutischen zusammenstellungen zur behandlung von schlafstörungen | |
| SE9603284D0 (sv) | New compounds | |
| TR200402493T4 (tr) | Yeni 2,3-benzodiazepin türevleri ve aktif bileşen olarak bunları içeren farmasötik bileşimler. | |
| BR9507668A (pt) | Intermédio para preparar um composto farmaceuticamente atívo | |
| DE69400908D1 (de) | Verwendung von riluzol zum schutz gegen strahlenschäden | |
| FI850593L (fi) | N-(2,6-disubstituerade aromatiska) -n'-pyridinylureafoereningar. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |